An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Academic Journal of Biosciences | Volume-5 | Issue-12
Serum Prolactin in Rheumatoid Arthritis: A Possible Marker of Disease Activity
Dr. Aradhna Singh, Dr. C L Nawal, Dr. Sujata Agrawal, Dr Kamlesh Sharma, Dr. Laxmi Kant Goyal, Dr. R S Chejara
Published: Dec. 30, 2017 | 277 161
DOI: 10.36347/sajb.2017.v05i12.001
Pages: 836-841
Downloads
Abstract
Rheumatoid arthritis is the most common rheumatic disease which may lead to crippling deformity if not treated properly. Traditional marker of inflammation (ESR, CRP) loss their value in advancing age to ascertain disease activity and many patients continue to have active disease despite aggressive treatment. This study was an endeavor to assess serum prolactin levels in RA patients and its correlation with disease activity. An observational analytic case control study was carried out at a tertiary care center in North-West India among 20 post-menopausal women having rheumatoid arthritis (the case) (diagnosed as per revised American college of Rheumatology 2010 criteria) and 20 age matched healthy post-menopausal women (controls), in accordance with the declaration of Helsinki and after informed consent from participants and permission from institutional ethics committee. The healthy female relatives for the RA patients were taken as control. Females having possible causes of hyperprolactinemia other than RA i.e. deranged renal function test, liver disease, thyroid disorder, seizure and drugs (steroids, antipsychotics, metoclopramide, H2 antagonist, imipramines at least 2 weeks prior to the study) were excluded. After detailed history and thorough rheumatologic assessment; after overnight fasting, venous blood samples of the study participants were drawn from left anticubital vein between 09:30 AM to 12:00 hours noon (at least 2 hours after awakening) and sent for complete blood count, fasting plasma glucose, urea, creatinine, uric acid, SGOT, SGPT, ESR (by Westerngren method), rheumatoid factor (by nephelometry) and CRP (by nephelometry). Serum prolactin was measured by chemiluminescence Immunoassays (CLIA). RA disease activity was measured by DAS28. ESR was significantly higher among RA cases (38.05±24.16 mm/Isthr) compared to control subjects (14.65±8.26 mm/Isthr, p<0.05). Serum prolactin was significantly higher among RA cases (41.08±35.52 ng/ml) compared to non